Alpha Paradigm Partners’s ResMed RMD Stock Holding History

Alpha Paradigm Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$69K	Buy	+330	New	+$72.5K	0.03%	406
2022 Q3	–	Sell	-162	Closed	-$34K	–	610
2022 Q2	$34K	Hold	162	–	–	0.01%	455
2022 Q1	$39K	Hold	162	–	–	0.02%	487
2021 Q4	$42K	Hold	162	–	–	0.02%	480
2021 Q3	$43K	Hold	162	–	–	0.02%	471
2021 Q2	$40K	Sell	162 -21	-11%	-$4.42K	0.02%	489
2021 Q1	$36K	Sell	183 -276	-60%	-$55.3K	0.01%	436
2020 Q4	$98K	Buy	+459	New	+$91.5K	0.03%	321

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Alpha Paradigm Partners's RMD Position: Q4 2022 in Review

Alpha Paradigm Partners opened a new position in ResMed (RMD) in Q4 2022: 330 shares worth $69K. The stake represents 0.03% of the portfolio and ranks #406 among its holdings. This is a return to the name: Alpha Paradigm Partners previously reported a position in RMD as recently as Q2 2022.

Alpha Paradigm Partners first reported a position in RMD in Q4 2020 and has held it in 8 quarters since. The position peaked at $98K in Q4 2020. 731 funds tracked by Wall St. Rank hold RMD as of Q4 2022.

Alpha Paradigm Partners held 330 shares of ResMed worth $69K as of Q4 2022.
ResMed was a new Alpha Paradigm Partners position in Q4 2022.
ResMed made up 0.03% of Alpha Paradigm Partners's portfolio in Q4 2022, its #406 holding.
Alpha Paradigm Partners first reported a position in ResMed in Q4 2020 and has held it in 8 quarters since.
Alpha Paradigm Partners's ResMed position peaked at $98K in Q4 2020.
731 funds tracked by Wall St. Rank held ResMed as of Q4 2022.

Based on Alpha Paradigm Partners's 13F filing for Q4 2022, filed 13 Feb 2023.